Track And Trace System Could Start With RxTEC As Foundation, FDA Says Compromise proposal from agency would allow lot-level tracking at first, if there was a "clear path" to a more advanced system in subsequent years.
Vaccine Autism Liability Cases Disappearing, DoJ Reports With no claims filed in the last three months, the legal tide appears to have turned decisively against claims that childhood vaccines cause autism. Also, GSK's Menhibrix finally wins approval, and with an advantageous age range.
NIH Translational Science Center Would Get 10% Funding Boost In Senate Bill Appropriations Committee recommends BARDA receive a 12% increase over its fiscal 2012 appropriations in the report accompanying the Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations bill sent to the floor on a party-line vote of 16-14, June 14.
Novo Nordisk Partners With JDRF In Type 1 Diabetes Push Novo Nordisk will conduct early research around the underlying autoimmune process central to type 1 diabetes in a partnership with JDRF; the company simultaneously opened its Type 1 Diabetes R&D Center in Seattle.
Third Rock Pumps $41 Million Into Global Blood Therapeutics In the firm's largest solo investment ever, Third Rock backed a new platform company that will seek to identify and develop a pipeline of drugs for rare blood disorders.
“The Pink Sheet” DAILY - daily in-depth analysis of the key developments shaping the biopharma industry. For more information call 1-800-332-2181. To register for a free trial, click here – no credit card needed.